Breaking News Instant updates and real-time market news.

PUMP

ProPetro Holding

$7.34

-0.36 (-4.68%)

18:33
11/13/19
11/13
18:33
11/13/19
18:33

ProPetro discloses U.S. SEC probe

ProPetro has filed a Current Report on Form 8-K that provides updates regarding the audit committee's internal review, as well as related accounting conclusions regarding the existence of at least two material weaknesses, recently filed shareholder litigation, a Securities and Exchange Commission investigation and related matters. The audit committee has continued to review the matters previously disclosed in the company's Current Reports on Form 8-K filed with the SEC on August 8, 2019 and October 9, 2019. Since October 9, 2019, the Audit Committee has identified one related party transaction that was not previously disclosed and is described in greater detail in the Form 8-K. The company and certain of its officers and directors have been named in a shareholder class action lawsuit that was filed in September 2019 and remains in its early stages. The company has also been advised by the SEC that the SEC has opened an investigation into the company, and the company has cooperated and expects to continue to cooperate with the SEC's investigation. The company cannot currently predict the duration, scope or results of either of these proceedings, including whether either or both may have a material adverse impact on the company. ProPetro has also filed a Form 12b-25, Notification of Late Filing, with the SEC today regarding its inability to timely file its Form 10-Q for the third quarter of 2019. The company does not currently expect to be in a position to file amended, delinquent or future SEC filings prior to the end of 2019. As described in the Form 8-K and Form 12b-25, the company will continue to seek to take all appropriate actions and make necessary filings with the SEC with a view to becoming current in its filing obligations under the Securities Exchange Act of 1934, as amended, as soon as reasonably practicable.

  • 14

    Nov

  • 14

    Nov

PUMP ProPetro Holding
$7.34

-0.36 (-4.68%)

09/12/19
COWN
09/12/19
DOWNGRADE
Target $11
COWN
Market Perform
ProPetro Holding downgraded to Market Perform from Outperform at Cowen
Cowen analyst Marc Bianchi downgraded ProPetro Holdings to Market Perform form Outperform. The analyst noted the company has passed its 30-day review period from when the company announced an internal issue and no update has been given. He believes the audit committee's review will likely be a binary event for the stock which he has no comfort in estimating. Bianchi has an $11 price target on ProPetro Holdings shares.
10/10/19
PIPR
10/10/19
UPGRADE
Target $12
PIPR
Overweight
ProPetro Holding upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst John Daniel upgraded ProPetro Holding to Overweight from Neutral with a price target of $12, down from $17. Last night's investigation update is encouraging and does not point to any evidence of a government investigation. Daniel tells investors in a research note. . One would assume if any investigation of that type were underway, it would be disclosed, says the analyst.
10/10/19
RAJA
10/10/19
NO CHANGE
Target $14
RAJA
Outperform
ProPetro price target lowered to $14 from $20 at Raymond James
Raymond James analyst Praveen Narra lowered his price target for ProPetro Holdings to $14 from $20 after the company announced that its internal review is substantially complete. While the review will result in several management roles being different, management as a whole is largely intact with Dale Redman remaining as the CEO, which should remove a large overhang, Narra tells investors in a research note. With the largest overhang of the investigation removed, NArra expects the stock to outperform despite the weak guidance. He reiterates an Outperform rating.
10/18/19
RILY
10/18/19
NO CHANGE
Target $17
RILY
Buy
ProPetro Holding price target lowered to $17 from $29 at B. Riley FBR
B. Riley FBR analyst Thomas Curran lowered his price target for ProPetro Holding to $17 from $29 citing the "lingering unknowns" of the audit committee's review of internal and disclosure controls. The analyst, however, finds ProPetro's latest update, especially the management changes, encouraging and believes the stock's risk/reward "remains compelling." He keeps a Buy rating on the shares.

TODAY'S FREE FLY STORIES

08:52
12/09/19
12/09
08:52
12/09/19
08:52
Conference/Events
Jefferies European economist to hold an analyst/industry conference call »

European Economist Owen,…

LEA

Lear

$124.81

4.05 (3.35%)

08:51
12/09/19
12/09
08:51
12/09/19
08:51
Conference/Events
Lear management to meet with UBS »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

WWD

Woodward

$122.27

2.55 (2.13%)

08:49
12/09/19
12/09
08:49
12/09/19
08:49
Recommendations
Woodward analyst commentary  »

Woodward…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JKS

JinkoSolar

$20.32

0.56 (2.83%)

08:49
12/09/19
12/09
08:49
12/09/19
08:49
Conference/Events
JinkoSolar management to meet with Roth Capital »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

ABEO

Abeona Therapeutics

$3.00

0.25 (9.09%)

08:46
12/09/19
12/09
08:46
12/09/19
08:46
Hot Stocks
Abeona Therapeutics cleared to initiate EB-101 Phase 3 clinical trial »

Abeona Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JEC

Jacobs Engineering

$85.02

-0.56 (-0.65%)

08:46
12/09/19
12/09
08:46
12/09/19
08:46
Conference/Events
Jacobs Engineering management to meet with Seaport Global »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

DK

Delek US

$34.30

0.99 (2.97%)

, MPC

Marathon Petroleum

$60.17

0.4 (0.67%)

08:46
12/09/19
12/09
08:46
12/09/19
08:46
Downgrade
Delek US, Marathon Petroleum rating change  »

JPMorgan downgrades Delek…

DK

Delek US

$34.30

0.99 (2.97%)

MPC

Marathon Petroleum

$60.17

0.4 (0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BZUN

Baozun

$35.29

-0.06 (-0.17%)

, AIMT

Aimmune

$29.67

0.51 (1.75%)

08:45
12/09/19
12/09
08:45
12/09/19
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

BZUN

Baozun

$35.29

-0.06 (-0.17%)

AIMT

Aimmune

$29.67

0.51 (1.75%)

MED

Medifast

$90.67

0.48 (0.53%)

CGC

Canopy Growth

$18.65

0.07 (0.38%)

UVXY

ProShares Trust Ultra VIX Short Term Futures ETF

$15.11

-0.8 (-5.03%)

SCO

Scor ADR

$13.14

-0.3 (-2.23%)

BRFS

BRF S.A.

$8.87

0.22 (2.54%)

ET

Energy Transfer LP

$11.50

-0.1 (-0.86%)

RVLV

Revolve Group

$16.74

-0.46 (-2.67%)

DO

Diamond Offshore

$6.01

0.44 (7.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

INFN

Infinera

$6.12

0.115 (1.92%)

08:44
12/09/19
12/09
08:44
12/09/19
08:44
Conference/Events
Infinera management to meet with B. Riley FBR »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 10

    Dec

DPLO

Diplomat Pharmacy

$5.82

0.22 (3.93%)

08:43
12/09/19
12/09
08:43
12/09/19
08:43
Downgrade
Diplomat Pharmacy rating change  »

Diplomat Pharmacy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IHRT

iHeartMedia

$14.59

-0.24 (-1.62%)

08:42
12/09/19
12/09
08:42
12/09/19
08:42
Conference/Events
iHeartMedia management to meet with Wolfe Research »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

IDA

Idacorp

$104.61

-0.03 (-0.03%)

08:40
12/09/19
12/09
08:40
12/09/19
08:40
Conference/Events
Idacorp management to meet with Mizuho »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

ATVI

Activision Blizzard

$55.21

0.22 (0.40%)

08:39
12/09/19
12/09
08:39
12/09/19
08:39
Recommendations
Activision Blizzard analyst commentary  »

Activision Blizzard price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

SNY

Sanofi

$46.05

-0.04 (-0.09%)

08:38
12/09/19
12/09
08:38
12/09/19
08:38
Hot Stocks
Sanofi vaccines unit enters agreement with HHS to increase production capability »

Sanofi Pasteur, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

RFIL

RF Industries

$5.82

0.07 (1.22%)

08:38
12/09/19
12/09
08:38
12/09/19
08:38
Hot Stocks
RF Industries appoints Ray Bibisi as Chief Revenue Officer »

RF Industries announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JJSF

J & J Snack Foods

$188.98

0.94 (0.50%)

08:37
12/09/19
12/09
08:37
12/09/19
08:37
Downgrade
J & J Snack Foods rating change  »

J & J Snack Foods…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPE

HP Enterprise

$15.91

-0.02 (-0.13%)

08:37
12/09/19
12/09
08:37
12/09/19
08:37
Conference/Events
HP Enterprise management to meet with Loop Capital »

Dinner Meeting with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

  • 10

    Dec

ATR

AptarGroup

$112.05

-0.015 (-0.01%)

08:36
12/09/19
12/09
08:36
12/09/19
08:36
Hot Stocks
AptarGroup Unidose Liquid System approved by FDA »

AptarGroup announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTON

Peloton

$32.56

1.24 (3.96%)

08:35
12/09/19
12/09
08:35
12/09/19
08:35
Recommendations
Peloton analyst commentary  »

Peloton remains positoned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

FLWS

1-800-Flowers.com

$12.83

-0.09 (-0.70%)

08:34
12/09/19
12/09
08:34
12/09/19
08:34
Conference/Events
1-800-Flowers.com management to meet with DA Davidson »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 10

    Dec

PDLI

PDL BioPharma

$2.96

-0.035 (-1.17%)

, EVFM

Evofem

$6.88

0.455 (7.09%)

08:33
12/09/19
12/09
08:33
12/09/19
08:33
Hot Stocks
PDL BioPharma completes strategic review, to initiate new process »

PDL BioPharma (PDLI)…

PDLI

PDL BioPharma

$2.96

-0.035 (-1.17%)

EVFM

Evofem

$6.88

0.455 (7.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EA

Electronic Arts

$103.30

1.22 (1.20%)

08:32
12/09/19
12/09
08:32
12/09/19
08:32
Recommendations
Electronic Arts analyst commentary  »

Electronic Arts price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

ARQL

ArQule

$9.67

0.15 (1.58%)

, AUTL

Autolus Therapeutics

$14.60

-0.18 (-1.22%)

08:30
12/09/19
12/09
08:30
12/09/19
08:30
Conference/Events
Roth Capital to hold events »

Roth Capital KOL Events…

ARQL

ArQule

$9.67

0.15 (1.58%)

AUTL

Autolus Therapeutics

$14.60

-0.18 (-1.22%)

BGNE

BeiGene

$186.89

-2.3 (-1.22%)

BLUE

Bluebird Bio

$79.51

-1.24 (-1.54%)

BMY

Bristol-Myers

$59.94

0.435 (0.73%)

CC

Chemours

$16.68

1.62 (10.76%)

CRSP

Crispr Therapeutics

$72.19

1.47 (2.08%)

FTSV

Forty Seven

$14.40

0.23 (1.62%)

JNJ

Johnson & Johnson

$140.36

0.79 (0.57%)

LLY

Eli Lilly

$119.59

-0.175 (-0.15%)

LOXO

Loxo Oncology

$0.00

(0.00%)

SGMO

Sangamo

$11.65

0.05 (0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 11

    Dec

  • 17

    Dec

  • 21

    Jan

  • 30

    Jan

  • 27

    Feb

TFC

Taiwan Greater China Fund

$54.16

0.66 (1.23%)

, BBT

BB&T

$54.16

0.66 (1.23%)

08:30
12/09/19
12/09
08:30
12/09/19
08:30
Options
One new option listing and two option delistings on December 9th »

New option listings for…

TFC

Taiwan Greater China Fund

$54.16

0.66 (1.23%)

BBT

BB&T

$54.16

0.66 (1.23%)

STI

SunTrust

$70.09

0.83 (1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

CWBHF

Charlotte's Web

$0.00

(0.00%)

08:29
12/09/19
12/09
08:29
12/09/19
08:29
Initiation
Charlotte's Web initiated  »

Compass Point starts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.